Curtin Matheson to distribute Bard's BTA test:
This article was originally published in Clinica
Curtin Matheson Scientific is to distribute Bard's BTA bladder cancer test in the US. The Bard kit, which is the only test of its kind with FDA approval, will cost around $17 each. It has been available in Europe for over a year. Curtin is a wholly-owned subsidiary of Fisher Scientific International.
You may also be interested in...
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.